Ray Therapeutics

Vision, Reimagined.

Ray Therapeutics is a biotech company in Berkeley, United States, founded in 2021. It has raised $241.0M across 5 rounds, most recently a $125.0M Series B in April 2026.

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$241.0M
Last Round
$125.0M Series BApr 2026
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 6 investors for this company. to use credits for reveals, or explore the API.

About

Ray Therapeutics is a clinical-stage biopharmaceutical company developing optogenetic gene therapies for patients with blinding diseases including retinitis pigmentosa, Stargardt's disease, and geographic atrophy. Its lead program RTx-015 received FDA Regenerative Medicine Advanced Therapy (RMAT) designation in 2026. The company's technology reprograms surviving retinal neurons to restore vision independent of genetic mutation.

Funding History

Data from Indexed.vcUpdated
Series BSeries BApr 2026
$125.0M

4 more events

  • Grant20251 investor
  • Grant20231 investor
  • Series A20235 investors

Funding: Grant through Series B. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×1
  • Marketing & SEO ×1
  • Productivity & Collaboration ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech
Corporate RoundTotal funding$1.0BApr 2020
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech
Corporate RoundTotal funding$730.0MDec 2025
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech
Series BTotal funding$650.0MOct 2025
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech
Corporate RoundTotal funding$2.1BJun 2026
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ray Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ray-therapeutics"><img src="https://indexed.vc/api/badge/company/ray-therapeutics" alt="Ray Therapeutics on Indexed.vc" width="260" height="76" /></a>